PBYI icon

Puma Biotechnology
PBYI

Overview Fund Activity

115 hedge funds and large institutions have $226M invested in Puma Biotechnology in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 51 increasing their positions, 35 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
-4
Holders Change %
-3.36%
% of All Funds
2.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
51
Reduced
35
Closed
15
Calls
$878K
Puts
$441K
Net Calls
+$437K
Net Calls Change
+$7K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$11.7M
2
CCM
2
Camber Capital Management
Massachusetts
$24M
3
Goldman Sachs
3
Goldman Sachs
New York
$5.66M
4
EP
4
Eversept Partners
New York
$2.79M
5
Russell Investments Group
5
Russell Investments Group
United Kingdom
$2.54M

Top Sellers

1
DM
1
Deerfield Management
New York
$0
2
State Street
2
State Street
Massachusetts
$4.47M
3
JAM
3
Jupiter Asset Management
United Kingdom
$0
4
FAM
4
Fred Alger Management
New York
$17.3M
5
ACM
5
AIGH Capital Management
Maryland
$6.06M
Name Holding Trade Value Shares
Change 		Shares
Change %
BFM
126
Boothbay Fund Management
New York
– -$114K -12,385 Closed
OPS
127
Orion Portfolio Solutions
Nebraska
– -$113K -12,296 Closed
DekaBank Deutsche Girozentrale
128
DekaBank Deutsche Girozentrale
Germany
– -$71K -8,000 Closed
Lazard Asset Management
129
Lazard Asset Management
New York
– -$64K -6,984 Closed
PHK
130
Point72 Hong Kong
Hong Kong
– -$49K -5,315 Closed
IA
131
IFP Advisors
Florida
– -$12K -1,463 Closed
2 3 4 5
6